
Featured
Breakthrough in Alzheimer's Treatment: Blood-Brain Barrier Penetrating Antibody Clears Plaques in Phase 3
Biogen and Eisai report Phase 3 success for NeuroClear, a bispecific antibody that crosses the blood-brain barrier via the transferrin receptor. The d...
Read Full Story →
